Ian W. Frank, Ph.D. - Publications

Affiliations: 
2013 Applied Physics Harvard University, Cambridge, MA, United States 
Area:
Optics Physics

26/184 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Perkinson JC, Moebius MG, Brundage EJ, Teynor WA, Byrnes SJ, Hsiao JC, Sawyer WD, Callahan DM, Frank IW, LeBlanc JJ, Favalora GE. Surface-emitting electroholographic SAW modulator. Optics Express. 28: 1585-1594. PMID 32121866 DOI: 10.1364/Oe.381575  0.361
2018 Hammond AM, Frank IW, Camacho RM. Error Correction in Structured Optical Receivers Ieee Journal of Selected Topics in Quantum Electronics. 24: 1-8. DOI: 10.1109/Jstqe.2018.2846024  0.331
2014 Frank IW, Zhang Y, Loncar M. Nearly arbitrary on-chip optical filters for ultrafast pulse shaping. Optics Express. 22: 22403-10. PMID 25321711 DOI: 10.1364/Oe.22.022403  0.678
2014 Ramos D, Frank IW, Deotare PB, Bulu I, Lončar M. Non-linear mixing in coupled photonic crystal nanobeam cavities due to cross-coupling opto-mechanical mechanisms Applied Physics Letters. 105. DOI: 10.1063/1.4901441  0.749
2013 Quan Q, Floyd DL, Burgess IB, Deotare PB, Frank IW, Tang SK, Ilic R, Loncar M. Single particle detection in CMOS compatible photonic crystal nanobeam cavities. Optics Express. 21: 32225-33. PMID 24514817 DOI: 10.1364/Oe.21.032225  0.776
2013 Yu CL, Kim H, de Leon N, Frank IW, Robinson JT, McCutcheon M, Liu M, Lukin MD, Loncar M, Park H. Stretchable photonic crystal cavity with wide frequency tunability. Nano Letters. 13: 248-52. PMID 23245191 DOI: 10.1021/Nl303987Y  0.687
2013 Frish MB, Shankar R, Bulu I, Frank I, Laderer MC, Wainner RT, Allen MG, Lončar M. Progress toward mid-IR chip-scale integrated-optic TDLAS gas sensors Proceedings of Spie - the International Society For Optical Engineering. 8631. DOI: 10.1117/12.2008953  0.711
2013 Burek MJ, Ramos D, Patel P, Frank IW, Lončar M. Nanomechanical resonant structures in single-crystal diamond Applied Physics Letters. 103. DOI: 10.1063/1.4821917  0.654
2012 Deotare PB, Bulu I, Frank IW, Quan Q, Zhang Y, Ilic R, Loncar M. All optical reconfiguration of optomechanical filters. Nature Communications. 3: 846. PMID 22617286 DOI: 10.1038/Ncomms1830  0.807
2012 Deotare PB, Bulu I, Frank IW, Quan Q, Ilic R, Loncar M. All optical control of optomechanical filters 2012 Conference On Lasers and Electro-Optics, Cleo 2012 0.481
2012 Deotare PB, Bulu I, Frank IW, Quan Q, Ilic R, Loncar M. All optical control of optomechanical filters 2012 Conference On Lasers and Electro-Optics, Cleo 2012 0.74
2012 Deotare PB, Bulu I, Frank IW, Quan Q, Ilic R, Loncar M. All optical control of optomechanical filters 2012 Conference On Lasers and Electro-Optics, Cleo 2012 0.796
2011 Deotare PB, Frank I, Bulu I, Quan Q, Ilic R, Loncar M. All-optical control of opto-mechanical properties of photonic crystal nano-beam filter Ieee International Conference On Group Iv Photonics Gfp. 193-195. DOI: 10.1109/GROUP4.2011.6053760  0.807
2011 Quan Q, Vollmer F, Burgess IB, Deotare PB, Frank IW, Sindy KYT, Illic R, Loncar M. Ultrasensitive on-chip photonic crystal nanobeam sensor using optical bistability 2011 Conference On Lasers and Electro-Optics: Laser Science to Photonic Applications, Cleo 2011 0.748
2011 Quan Q, Vollmer F, Burgess IB, Deotare PB, Frank IW, Tang SKY, Illic R, Loncar M. Ultrasensitive on-chip photonic crystal nanobeam sensor using optical bistability Optics Infobase Conference Papers 0.795
2011 Quan Q, Burgess IB, Tang SKY, Floyd DL, Deotare PB, Frank IW, Ilic R, Vollmer F, Loncar M. Label-free sensing with photonic crystal nanobeam cavities 15th International Conference On Miniaturized Systems For Chemistry and Life Sciences 2011, Microtas 2011. 3: 1962-1964.  0.804
2010 Frank IW, Deotare PB, McCutcheon MW, Loncar M. Programmable photonic crystal nanobeam cavities. Optics Express. 18: 8705-12. PMID 20588714 DOI: 10.1364/Oe.18.008705  0.801
2010 Frank IW, Deotare PB, McCutcheon MW, Lonèar M. Programmable photonic crystal nanobeam cavities Optics Express. 18: 8705-8712. DOI: 10.1364/OE.18.008705  0.775
2010 Loncar M, Deotare PB, Frank IW, Zhang Y, Conwill A, Khan M, McCutcheon MW, Quan Q. Photonic crystal nanobeam cavities and their applications Optics Infobase Conference Papers 0.798
2010 Loncar M, Deotare PB, Frank IW, Zhang Y, Conwill A, Khan M, McCutcheon MW, Quan Q. Photonic crystal nanobeam cavities and their applications Lasers and Electro-Optics/Quantum Electronics and Laser Science Conference: 2010 Laser Science to Photonic Applications, Cleo/Qels 2010 0.767
2009 Deotare PB, McCutcheon MW, Frank IW, Khan M, Lončar M. Coupled photonic crystal nanobeam cavities Applied Physics Letters. 95. DOI: 10.1063/1.3176442  0.769
2009 Deotare PB, McCutcheon MW, Frank IW, Khan M, Lončar M. High quality factor photonic crystal nanobeam cavities Applied Physics Letters. 94. DOI: 10.1063/1.3107263  0.78
2009 Deotare PB, McCutcheon MW, Frank IW, Khan M, Shankar R, Loncar M. High quality factor 1D photonic crystal cavities in silicon 2009 Conference On Lasers and Electro-Optics and 2009 Conference On Quantum Electronics and Laser Science Conference, Cleo/Qels 2009 0.798
2009 Deotare PB, McCutcheon MW, Frank IW, Khan M, Shankar R, Loncar M. High quality factor 1D photonic crystal cavities in silicon 2009 Conference On Lasers and Electro-Optics and 2009 Conference On Quantum Electronics and Laser Science Conference, Cleo/Qels 2009 0.759
2009 Loncar M, Deotare PB, McCutcheon MW, Khan M, Zhang Y, Frank IW, Babinec T, Chang DE, Lukin MD. High quality factor photonic crystal nanobeam cavities and their applications Optics Infobase Conference Papers 0.803
2007 Bunch JS, van der Zande AM, Verbridge SS, Frank IW, Tanenbaum DM, Parpia JM, Craighead HG, McEuen PL. Electromechanical resonators from graphene sheets. Science (New York, N.Y.). 315: 490-3. PMID 17255506 DOI: 10.1126/Science.1136836  0.401
Low-probability matches (unlikely to be authored by this person)
2014 Luk TS, Fofang NT, Cruz-Campa JL, Frank I, Campione S. Surface plasmon polariton enhanced ultrathin nano-structured CdTe solar cell. Optics Express. 22: A1372-9. PMID 25322192 DOI: 10.1364/Oe.22.0A1372  0.284
2007 Frank IW, Tanenbaum DM, Van Der Zande AM, McEuen PL. Mechanical properties of suspended graphene sheets Journal of Vacuum Science and Technology B: Microelectronics and Nanometer Structures. 25: 2558-2561. DOI: 10.1116/1.2789446  0.231
2008 Bisson GP, Rowh A, Weinstein R, Gaolathe T, Frank I, Gross R. Antiretroviral failure despite high levels of adherence: discordant adherence-response relationship in Botswana. Journal of Acquired Immune Deficiency Syndromes. 49: 107-110. PMID 18667926 DOI: 10.1097/Qai.0B013E3181820141  0.077
2013 Chhatre S, Metzger DS, Frank I, Boyer J, Thompson E, Nidich S, Montaner LJ, Jayadevappa R. Effects of behavioral stress reduction Transcendental Meditation intervention in persons with HIV. Aids Care. 25: 1291-7. PMID 23394825 DOI: 10.1080/09540121.2013.764396  0.063
2008 Yu JJ, Wu TL, Liszewski MK, Dai J, Swiggard WJ, Baytop C, Frank I, Levine BL, Yang W, Theodosopoulos T, O'Doherty U. A more precise HIV integration assay designed to detect small differences finds lower levels of integrated DNA in HAART treated patients. Virology. 379: 78-86. PMID 18649912 DOI: 10.1016/J.Virol.2008.05.030  0.062
2014 Bittinger K, Charlson ES, Loy E, Shirley DJ, Haas AR, Laughlin A, Yi Y, Wu GD, Lewis JD, Frank I, Cantu E, Diamond JM, Christie JD, Collman RG, Bushman FD. Improved characterization of medically relevant fungi in the human respiratory tract using next-generation sequencing. Genome Biology. 15: 487. PMID 25344286 DOI: 10.1186/S13059-014-0487-Y  0.053
2007 Bakshi RP, Hamzeh F, Frank I, Eron JJ, Bosch RJ, Rosenkranz SL, Cramer YS, Ussery M, Flexner C. Effect of hydroxyurea and dideoxyinosine on intracellular 3'-deoxyadenosine-5'-triphosphate concentrations in HIV-infected patients. Aids Research and Human Retroviruses. 23: 1360-5. PMID 18184078 DOI: 10.1089/Aid.2007.0078  0.053
2004 Vogler MA, Teppler H, Gelman R, Valentine F, Lederman MM, Pomerantz RJ, Pollard RB, Cherng DW, Gonzalez CJ, Squires KE, Frank I, Mildvan D, Mahon LF, Schock B. Daily low-dose subcutaneous interleukin-2 added to single- or dual-nucleoside therapy in HIV infection does not protect against CD4+ T-cell decline or improve other indices of immune function: results of a randomized controlled clinical trial (ACTG 248). Journal of Acquired Immune Deficiency Syndromes (1999). 36: 576-87. PMID 15097300 DOI: 10.1097/00126334-200405010-00005  0.053
2004 Frank I, Bosch RJ, Fiscus S, Valentine F, Flexner C, Segal Y, Ruan P, Gulick R, Wood K, Estep S, Fox L, Nevin T, Stevens M, Eron JJ. Activity, safety, and immunological effects of hydroxyurea added to didanosine in antiretroviral-naive and experienced HIV type 1-infected subjects: a randomized, placebo-controlled trial, ACTG 307. Aids Research and Human Retroviruses. 20: 916-26. PMID 15597521 DOI: 10.1089/Aid.2004.20.916  0.052
2013 McKittrick N, Frank I, Jacobson JM, White CJ, Kim D, Kappes R, DiGiorgio C, Kenney T, Boyer J, Tebas P. Improved immunogenicity with high-dose seasonal influenza vaccine in HIV-infected persons: a single-center, parallel, randomized trial. Annals of Internal Medicine. 158: 19-26. PMID 23277897 DOI: 10.7326/0003-4819-158-1-201301010-00005  0.049
2008 Bisson GP, Gross R, Bellamy S, Chittams J, Hislop M, Regensberg L, Frank I, Maartens G, Nachega JB. Pharmacy Refill Adherence Compared with CD4 Count Changes for Monitoring HIV-Infected Adults on Antiretroviral Therapy Plos Medicine. 5: 777-788. PMID 18494555 DOI: 10.1371/Journal.Pmed.0050109  0.049
2004 Tershakovec AM, Frank I, Rader D. HIV-related lipodystrophy and related factors Atherosclerosis. 174: 1-10. PMID 15135244 DOI: 10.1016/S0021-9150(03)00246-6  0.047
2005 Maecker HT, Rinfret A, D'Souza P, Darden J, Roig E, Landry C, Hayes P, Birungi J, Anzala O, Garcia M, Harari A, Frank I, Baydo R, Baker M, Holbrook J, et al. Standardization of cytokine flow cytometry assays Bmc Immunology. 6. PMID 15978127 DOI: 10.1186/1471-2172-6-13  0.046
2020 Bertagnolli LN, Varriale J, Sweet S, Brockhurst J, Simonetti FR, White J, Beg S, Lynn K, Mounzer K, Frank I, Tebas P, Bar KJ, Montaner LJ, Siliciano RF, Siliciano JD. Autologous IgG antibodies block outgrowth of a substantial but variable fraction of viruses in the latent reservoir for HIV-1. Proceedings of the National Academy of Sciences of the United States of America. PMID 33239444 DOI: 10.1073/pnas.2020617117  0.045
2023 Seaton KE, Huang Y, Karuna S, Heptinstall JR, Brackett C, Chiong K, Zhang L, Yates NL, Sampson M, Rudnicki E, Juraska M, deCamp AC, Edlefsen PT, Mullins JI, Williamson C, ... ... Frank I, et al. Pharmacokinetic serum concentrations of VRC01 correlate with prevention of HIV-1 acquisition. Ebiomedicine. 93: 104590. PMID 37300931 DOI: 10.1016/j.ebiom.2023.104590  0.043
2015 Eberhart MG, Yehia BR, Hillier A, Voytek CD, Fiore DJ, Blank M, Frank I, Metzger DS, Brady KA. Individual and community factors associated with geographic clusters of poor HIV care retention and poor viral suppression. Journal of Acquired Immune Deficiency Syndromes (1999). 69: S37-43. PMID 25867777 DOI: 10.1097/Qai.0000000000000587  0.043
2010 Hersperger AR, Pereyra F, Nason M, Demers K, Sheth P, Shin LY, Kovacs CM, Rodriguez B, Sieg SF, Teixeira-Johnson L, Gudonis D, Goepfert PA, Lederman MM, Frank I, Makedonas G, et al. Perforin expression directly ex vivo by HIV-specific CD8 T-cells is a correlate of HIV elite control. Plos Pathogens. 6: e1000917. PMID 20523897 DOI: 10.1371/Journal.Ppat.1000917  0.042
2007 Horton H, Thomas EP, Stucky JA, Frank I, Moodie Z, Huang Y, Chiu YL, McElrath MJ, De Rosa SC. Optimization and validation of an 8-color intracellular cytokine staining (ICS) assay to quantify antigen-specific T cells induced by vaccination Journal of Immunological Methods. 323: 39-54. PMID 17451739 DOI: 10.1016/j.jim.2007.03.002  0.042
2005 Nunnari G, Sullivan J, Xu Y, Nyirjesy P, Kulkosky J, Cavert W, Frank I, Pomerantz RJ. HIV type 1 cervicovaginal reservoirs in the era of HAART. Aids Research and Human Retroviruses. 21: 714-8. PMID 16131311 DOI: 10.1089/aid.2005.21.714  0.042
2015 Fuchs JD, Frank I, Elizaga ML, Allen M, Frahm N, Kochar N, Li S, Edupuganti S, Kalams SA, Tomaras GD, Sheets R, Pensiero M, Tremblay MA, Higgins TJ, Latham T, et al. First-in-Human Evaluation of the Safety and Immunogenicity of a Recombinant Vesicular Stomatitis Virus Human Immunodeficiency Virus-1 gag Vaccine (HVTN 090). Open Forum Infectious Diseases. 2: ofv082. PMID 26199949 DOI: 10.1093/Ofid/Ofv082  0.041
2011 Yehia B, Frank I. Battling AIDS in America: an evaluation of the National HIV/AIDS Strategy. American Journal of Public Health. 101: e4-8. PMID 21778507 DOI: 10.2105/AJPH.2011.300259  0.039
2022 Schuster DJ, Karuna S, Brackett C, Wesley MS, Li SS, Eisel N, Tenney D, Hilliard S, Yates NL, Heptinstall JR, Williams LD, Shen X, Rolfe R, Cabello R, Zhang L, ... ... Frank I, et al. Lower SARS-CoV-2 specific humoral immunity in People Living with HIV-1 recovered from non-hospitalized COVID-19. Jci Insight. PMID 36136590 DOI: 10.1172/jci.insight.158402  0.039
2023 Giron LB, Liu Q, Adeniji OS, Yin X, Kannan T, Ding J, Lu DY, Langan S, Zhang J, Azevedo JLLC, Hanna DB, Ofotokun I, Lazar J, Fischl MA, Haberlen S, ... ... Frank I, et al. Plasma Glycomic Markers of Accelerated Biological Aging During Chronic HIV Infection. Biorxiv : the Preprint Server For Biology. PMID 37609144 DOI: 10.1101/2023.08.09.551369  0.038
2006 Bisson GP, Frank I, Gross R, Lo Re V, Strom JB, Wang X, Mogorosi M, Gaolathe T, Ndwapi N, Friedman H, Strom BL, Dickinson D. Out-of-pocket costs of HAART limit HIV treatment responses in Botswana's private sector. Aids (London, England). 20: 1333-6. PMID 16816566 DOI: 10.1097/01.Aids.0000232245.36039.2B  0.038
2017 Markowitz M, Frank I, Grant RM, Mayer KH, Elion R, Goldstein D, Fisher C, Sobieszczyk ME, Gallant JE, Van Tieu H, Weinberg W, Margolis DA, Hudson KJ, Stancil BS, Ford SL, et al. Safety and tolerability of long-acting cabotegravir injections in HIV-uninfected men (ECLAIR): a multicentre, double-blind, randomised, placebo-controlled, phase 2a trial. The Lancet. Hiv. PMID 28546090 DOI: 10.1016/S2352-3018(17)30068-1  0.038
2010 Stewart P, Cachafeiro A, Napravnik S, Eron JJ, Frank I, van der Horst C, Bosch RJ, Bettendorf D, Bohlin P, Fiscus SA. Performance characteristics of the Cavidi ExaVir viral load assay and the ultra-sensitive P24 assay relative to the Roche Monitor HIV-1 RNA assay. Journal of Clinical Virology : the Official Publication of the Pan American Society For Clinical Virology. 49: 198-204. PMID 20832356 DOI: 10.1016/j.jcv.2010.07.022  0.037
2004 Horton H, Russell N, Moore E, Frank I, Baydo R, Havenar-Daughton C, Lee D, Deers M, Hudgens M, Weinhold K, McElrath MJ. Correlation between interferon-γ secretion and cytotoxicity, in virus-specific memory T cells Journal of Infectious Diseases. 190: 1692-1696. PMID 15478077 DOI: 10.1086/424490  0.037
2011 Charlson ES, Bittinger K, Haas AR, Fitzgerald AS, Frank I, Yadav A, Bushman FD, Collman RG. Topographical continuity of bacterial populations in the healthy human respiratory tract. American Journal of Respiratory and Critical Care Medicine. 184: 957-63. PMID 21680950 DOI: 10.1164/Rccm.201104-0655Oc  0.035
2006 Jacobson JM, Pat Bucy R, Spritzler J, Saag MS, Eron JJ, Coombs RW, Wang R, Fox L, Johnson VA, Cu-Uvin S, Cohn SE, Mildvan D, O'Neill D, Janik J, Purdue L, ... ... Frank I, et al. Evidence that intermittent structured treatment interruption, but not immunization with ALVAC-HIV vCP1452, promotes host control of HIV replication: the results of AIDS Clinical Trials Group 5068. The Journal of Infectious Diseases. 194: 623-32. PMID 16897661 DOI: 10.1086/506364  0.035
2024 Giron LB, Liu Q, Adeniji OS, Yin X, Kannan T, Ding J, Lu DY, Langan S, Zhang J, Azevedo JLLC, Li SH, Shalygin S, Azadi P, Hanna DB, Ofotokun I, ... ... Frank I, et al. Immunoglobulin G N-glycan markers of accelerated biological aging during chronic HIV infection. Nature Communications. 15: 3035. PMID 38600088 DOI: 10.1038/s41467-024-47279-4  0.034
2023 Etemad B, Sun X, Li Y, Melberg M, Moisi D, Gottlieb R, Ahmed H, Aga E, Bosch RJ, Acosta EP, Yuki Y, Martin MP, Carrington M, Gandhi RT, Jacobson JM, ... ... Frank I, et al. HIV post-treatment controllers have distinct immunological and virological features. Proceedings of the National Academy of Sciences of the United States of America. 120: e2218960120. PMID 36877848 DOI: 10.1073/pnas.2218960120  0.034
2002 Cohen C, Elion RA, Frank I, Kloser P, Sherer R, Squires KE, Steinhart C, Tebas P. Once-daily antiretroviral therapies for HIV infection: Consensus Statement of an Advisory Committee of the International Association of Physicians in AIDS Care. Journal of the International Association of Physicians in Aids Care (Chicago, Ill. : 2002). 1: 141-5. PMID 12942673 DOI: 10.1177/154510970200100406  0.034
2019 Ashare RL, Thompson M, Serrano K, Leone F, Metzger D, Frank I, Gross R, Hole A, Mounzer K, Collman RG, Wileyto EP, Schnoll R. Placebo-controlled randomized clinical trial testing the efficacy and safety of varenicline for smokers with HIV. Drug and Alcohol Dependence. 200: 26-33. PMID 31082665 DOI: 10.1016/J.Drugalcdep.2019.03.011  0.034
2008 Paiardini M, Frank I, Pandrea I, Apetrei C, Silvestri G. Mucosal immune dysfunction in AIDS pathogenesis. Aids Reviews. 10: 36-46. PMID 18385779  0.033
2018 Buggert M, Nguyen S, Salgado-Montes de Oca G, Bengsch B, Darko S, Ransier A, Roberts ER, Del Alcazar D, Brody IB, Vella LA, Beura L, Wijeyesinghe S, Herati RS, Del Rio Estrada PM, Ablanedo-Terrazas Y, ... ... Frank I, et al. Identification and characterization of HIV-specific resident memory CD8 T cells in human lymphoid tissue. Science Immunology. 3. PMID 29858286 DOI: 10.1126/Sciimmunol.Aar4526  0.033
2022 Herman JD, Wang C, Burke JS, Zur Y, Compere H, Kang J, Macvicar R, Taylor S, Shin S, Frank I, Siegel D, Tebas P, Choi GH, Shaw PA, Yoon H, et al. Nucleocapsid-specific antibody function is associated with therapeutic benefits from COVID-19 convalescent plasma therapy. Cell Reports. Medicine. 100811. PMID 36351430 DOI: 10.1016/j.xcrm.2022.100811  0.033
2015 Overton ET, Stapleton J, Frank I, Hassler S, Goepfert PA, Barker D, Wagner E, von Krempelhuber A, Virgin G, Meyer TP, Müller J, Bädeker N, Grünert R, Young P, Rösch S, et al. Safety and Immunogenicity of Modified Vaccinia Ankara-Bavarian Nordic Smallpox Vaccine in Vaccinia-Naive and Experienced Human Immunodeficiency Virus-Infected Individuals: An Open-Label, Controlled Clinical Phase II Trial. Open Forum Infectious Diseases. 2: ofv040. PMID 26380340 DOI: 10.1093/Ofid/Ofv040  0.032
2021 Jemmott JB, Jemmott LS, Zhang J, Icard LD, Kelly TA, Frank I, Bellamy SL. Effects of a Health Promotion Intervention on Physical Activity in African American Men Living with HIV: Randomized Controlled Trial. Aids Patient Care and Stds. PMID 34551263 DOI: 10.1089/apc.2021.0039  0.032
2022 Vakili S, Paneru B, Guerrier CM, Miller J, Baumrin E, Forrestel A, Lynn K, Frank I, Lo Re V, Collman RG, Hill DA. Altered adipose tissue macrophage populations in people with HIV on integrase inhibitor-containing ART. Aids (London, England). PMID 35848549 DOI: 10.1097/QAD.0000000000003278  0.032
2008 Bisson GP, Gaolathe T, Gross R, Rollins C, Bellamy S, Mogorosi M, Avalos A, Friedman H, Dickinson D, Frank I, Ndwapi N. Overestimates of survival after HAART: implications for global scale-up efforts. Plos One. 3: e1725. PMID 18320045 DOI: 10.1371/Journal.Pone.0001725  0.032
2024 Miner MD, deCamp A, Grunenberg N, De Rosa SC, Fiore-Gartland A, Bar K, Spearman P, Allen M, Yu PC, Manso B, Frahm N, Kalams S, Baden L, Keefer MC, Scott HM, ... ... Frank I, et al. Polytopic fractional delivery of an HIV vaccine alters cellular responses and results in increased epitope breadth in a phase 1 randomized trial. Ebiomedicine. 100: 104987. PMID 38306894 DOI: 10.1016/j.ebiom.2024.104987  0.032
2017 Harrison JD, Dochney JA, Blazekovic S, Leone F, Metzger D, Frank I, Gross R, Hole A, Mounzer K, Siegel S, Schnoll RA, Ashare RL. The nature and consequences of cognitive deficits among tobacco smokers with HIV: a comparison to tobacco smokers without HIV. Journal of Neurovirology. PMID 28429289 DOI: 10.1007/S13365-017-0526-Z  0.032
2020 Abdel-Mohsen M, Richman D, Siliciano RF, Nussenzweig MC, Howell BJ, Martinez-Picado J, Chomont N, Bar KJ, Yu XG, Lichterfeld M, Alcami J, Hazuda D, Bushman F, Siliciano JD, Betts MR, ... ... Frank I, et al. Recommendations for measuring HIV reservoir size in cure-directed clinical trials. Nature Medicine. PMID 32895573 DOI: 10.1038/S41591-020-1022-1  0.031
2013 Koblin BA, Metch B, Novak RM, Morgan C, Lucy D, Dunbar D, Graham P, Swann E, Madenwald T, Escamilia G, Frank I. Feasibility of identifying a cohort of US women at high risk for HIV infection for HIV vaccine efficacy trials: longitudinal results of HVTN 906. Journal of Acquired Immune Deficiency Syndromes (1999). 63: 239-44. PMID 23446497 DOI: 10.1097/Qai.0B013E31828Ded1A  0.031
2012 Yehia BR, Long JA, Stearns CR, French B, Tebas P, Frank I. Impact of transitioning from HIV clinical trials to routine medical care on clinical outcomes and patient perceptions. Aids Care. 24: 769-77. PMID 22106980 DOI: 10.1080/09540121.2011.630368  0.03
2006 Bisson GP, Gross R, Strom JB, Rollins C, Bellamy S, Weinstein R, Friedman H, Dickinson D, Frank I, Strom BL, Gaolathe T, Ndwapi N. Diagnostic accuracy of CD4 cell count increase for virologic response after initiating highly active antiretroviral therapy. Aids (London, England). 20: 1613-9. PMID 16868442 DOI: 10.1097/01.Aids.0000238407.00874.Dc  0.03
2007 Lo Re V, Frank I, Gross R, Dockter J, Linnen JM, Giachetti C, Tebas P, Stern J, Synnestvedt M, Localio AR, Kostman JR, Strom BL. Prevalence, risk factors, and outcomes for occult hepatitis B virus infection among HIV-infected patients. Journal of Acquired Immune Deficiency Syndromes (1999). 44: 315-20. PMID 17159655 DOI: 10.1097/Qai.0B013E31802Ea499  0.03
2024 Frank I, Li SS, Grunenberg N, Overton ET, Robinson ST, Zheng H, Seaton KE, Heptinstall JR, Allen MA, Mayer KH, Culver DA, Keefer MC, Edupuganti S, Pensiero MN, Mehra VL, et al. Safety and immunogenicity of a polyvalent DNA-protein HIV vaccine with matched Env immunogens delivered as a prime-boost regimen or coadministered in HIV-uninfected adults in the USA (HVTN 124): a phase 1, placebo-controlled, double-blind randomised controlled trial. The Lancet. Hiv. 11: e285-e299. PMID 38692824 DOI: 10.1016/S2352-3018(24)00036-5  0.029
2021 Edupuganti S, Mgodi N, Karuna ST, Andrew P, Rudnicki E, Kochar N, deCamp A, De La Grecca R, Anderson M, Karg C, Tindale I, Greene E, Broder GB, Lucas J, Hural J, ... ... Frank I, et al. Feasibility and Successful Enrollment in a Proof-of-Concept HIV Prevention Trial of VRC01, a Broadly Neutralizing HIV-1 Monoclonal Antibody. Journal of Acquired Immune Deficiency Syndromes (1999). PMID 33587505 DOI: 10.1097/QAI.0000000000002639  0.029
2003 Kemper CA, Haubrich R, Frank I, Dubin G, Buscarino C, McCutchan JA, Deresinski SC. Safety and immunogenicity of hepatitis A vaccine in human immunodeficiency virus-infected patients: a double-blind, randomized, placebo-controlled trial. The Journal of Infectious Diseases. 187: 1327-31. PMID 12696015 DOI: 10.1086/374562  0.029
2021 Astronomo RD, Lemos MP, Narpala SR, Czartoski J, Ballweber Fleming L, Seaton KE, Prabhakaran M, Huang Y, Lu Y, Westerberg K, Zhang L, Gross MK, Hural J, Tieu HV, Baden LR, ... ... Frank I, et al. Rectal and vaginal tissue from intravenous VRC01 recipients show protection against ex vivo HIV-1 challenge. The Journal of Clinical Investigation. PMID 34166231 DOI: 10.1172/JCI146975  0.029
2020 Buggert M, Vella LA, Nguyen S, Wu VH, Chen Z, Sekine T, Perez-Potti A, Maldini CR, Manne S, Darko S, Ransier A, Kuri-Cervantes L, Japp AS, Brody IB, Ivarsson MA, ... ... Frank I, et al. The Identity of Human Tissue-Emigrant CD8 T Cells. Cell. PMID 33306960 DOI: 10.1016/j.cell.2020.11.019  0.028
2015 Koblin BA, Grant S, Frye V, Superak H, Sanchez B, Lucy D, Dunbar D, Graham P, Madenwald T, Escamilia G, Swann E, Morgan C, Novak RM, Frank I. HIV Sexual Risk and Syndemics among Women in Three Urban Areas in the United States: Analysis from HVTN 906. Journal of Urban Health : Bulletin of the New York Academy of Medicine. 92: 572-83. PMID 25743100 DOI: 10.1007/S11524-015-9944-5  0.028
2012 Han JH, Crane HM, Bellamy SL, Frank I, Cardillo S, Bisson GP. HIV infection and glycemic response to newly initiated diabetic medical therapy Aids. 26: 2087-2095. PMID 22951636 DOI: 10.1097/Qad.0B013E328359A8E5  0.028
2019 Rouphael NG, Morgan C, Li SS, Jensen R, Sanchez B, Karuna S, Swann E, Sobieszczyk ME, Frank I, Wilson GJ, Tieu HV, Maenza J, Norwood A, Kobie J, Sinangil F, et al. DNA priming and gp120 boosting induces HIV-specific antibodies in a randomized clinical trial. The Journal of Clinical Investigation. PMID 31566579 DOI: 10.1172/Jci128699  0.028
2010 Sierra-Madero J, Di Perri G, Wood R, Saag M, Frank I, Craig C, Burnside R, McCracken J, Pontani D, Goodrich J, Heera J, Mayer H. Efficacy and safety of maraviroc versus efavirenz, both with zidovudine/lamivudine: 96-week results from the MERIT study. Hiv Clinical Trials. 11: 125-32. PMID 20736149 DOI: 10.1310/hct1103-125  0.027
2019 Neidich SD, Fong Y, Li SS, Geraghty DE, Williamson BD, Young WC, Goodman D, Seaton KE, Shen X, Sawant S, Zhang L, deCamp AC, Blette BS, Shao M, Yates NL, ... ... Frank I, et al. Antibody Fc effector functions and IgG3 associate with decreased HIV-1 risk. The Journal of Clinical Investigation. PMID 31589165 DOI: 10.1172/Jci126391  0.027
2005 Bisson GP, Strom BL, Gross R, Weissman D, Klinzman D, Hwang WT, Kostman JR, Metzger D, Stapleton JT, Frank I. Effect of GB virus C viremia on HIV acquisition and HIV set-point. Aids (London, England). 19: 1910-2. PMID 16227800 DOI: 10.1097/01.Aids.0000188427.25657.E7  0.027
2008 Lo Re V, Wertheimer B, Localio AR, Kostman JR, Dockter J, Linnen JM, Giachetti C, Dorey-Stein Z, Frank I, Strom BL, Gross R. Incidence of transaminitis among HIV-infected patients with occult hepatitis B. Journal of Clinical Virology : the Official Publication of the Pan American Society For Clinical Virology. 43: 32-6. PMID 18486540 DOI: 10.1016/J.Jcv.2008.03.030  0.027
2003 Yi Y, Chen W, Frank I, Cutilli J, Singh A, Starr-Spires L, Sulcove J, Kolson DL, Collman RG. An unusual syncytia-inducing human immunodeficiency virus type 1 primary isolate from the central nervous system that is restricted to CXCR4, replicates efficiently in macrophages, and induces neuronal apoptosis. Journal of Neurovirology. 9: 432-41. PMID 12907388 DOI: 10.1080/13550280390218706  0.026
2022 Pajon R, Paila YD, Girard B, Dixon G, Kacena K, Baden LR, El Sahly HM, Essink B, Mullane KM, Frank I, Denhan D, Kerwin E, Zhao X, Ding B, Deng W, et al. Initial analysis of viral dynamics and circulating viral variants during the mRNA-1273 Phase 3 COVE trial. Nature Medicine. PMID 35145311 DOI: 10.1038/s41591-022-01679-5  0.026
2013 Eberhart MG, Yehia BR, Hillier A, Voytek CD, Blank MB, Frank I, Metzger DS, Brady KA. Behind the cascade: analyzing spatial patterns along the HIV care continuum. Journal of Acquired Immune Deficiency Syndromes (1999). 64: S42-51. PMID 24126447 DOI: 10.1097/Qai.0B013E3182A90112  0.026
2014 Tebas P, Stein D, Tang WW, Frank I, Wang SQ, Lee G, Spratt SK, Surosky RT, Giedlin MA, Nichol G, Holmes MC, Gregory PD, Ando DG, Kalos M, Collman RG, et al. Gene editing of CCR5 in autologous CD4 T cells of persons infected with HIV. The New England Journal of Medicine. 370: 901-10. PMID 24597865 DOI: 10.1056/Nejmoa1300662  0.026
2020 Wood SM, Morales KH, Metzger D, Davis A, Fiore D, Petsis D, Barnett K, Koenig HC, Dowshen N, Gross R, Frank I. Mental Health, Social Influences, and HIV Pre-exposure Prophylaxis (PrEP) Utilization Among Men and Transgender Individuals Screening for HIV Prevention Trials. Aids and Behavior. PMID 32860114 DOI: 10.1007/S10461-020-03004-Y  0.025
2013 Azzoni L, Foulkes AS, Papasavvas E, Mexas AM, Lynn KM, Mounzer K, Tebas P, Jacobson JM, Frank I, Busch MP, Deeks SG, Carrington M, O'Doherty U, Kostman J, Montaner LJ. Pegylated Interferon alfa-2a monotherapy results in suppression of HIV type 1 replication and decreased cell-associated HIV DNA integration. The Journal of Infectious Diseases. 207: 213-22. PMID 23105144 DOI: 10.1093/Infdis/Jis663  0.025
2008 Plastaras JP, Vapiwala N, Ahmed MS, Gudonis D, Cerniglia GJ, Feldman MD, Frank I, Gupta AK. Validation and toxicity of PI3K/Akt pathway inhibition by HIV protease inhibitors in humans. Cancer Biology & Therapy. 7: 628-35. PMID 18285707 DOI: 10.4161/Cbt.7.5.5728  0.025
2008 Reynolds NR, Testa MA, Su M, Chesney MA, Neidig JL, Frank I, Smith S, Ickovics J, Robbins GK. Telephone support to improve antiretroviral medication adherence: a multisite, randomized controlled trial. Journal of Acquired Immune Deficiency Syndromes (1999). 47: 62-8. PMID 17891043 DOI: 10.1097/Qai.0B013E3181582D54  0.024
2013 Greenberg RN, Overton ET, Haas DW, Frank I, Goldman M, von Krempelhuber A, Virgin G, Bädeker N, Vollmar J, Chaplin P. Safety, immunogenicity, and surrogate markers of clinical efficacy for modified vaccinia Ankara as a smallpox vaccine in HIV-infected subjects. The Journal of Infectious Diseases. 207: 749-58. PMID 23225902 DOI: 10.1093/infdis/jis753  0.024
2017 Li SS, Kochar NK, Elizaga M, Hay CM, Wilson GJ, Cohen KW, De Rosa SC, Xu R, Ota-Setlik A, Morris D, Finak G, Allen M, Tieu HV, Frank I, Sobieszczyk ME, et al. DNA priming increases frequency of T-cell responses to a VSV HIV vaccine with specific enhancement of CD8(+) T-cell responses by IL-12 pDNA. Clinical and Vaccine Immunology : Cvi. PMID 28931520 DOI: 10.1128/Cvi.00263-17  0.024
2021 Denis CM, Dominique T, Smith P, Fiore D, Ku YC, Culhane A, Dunbar D, Brown D, Daramay M, Voytek C, Morales KH, Blank MB, Crits-Christoph PF, Douglas SD, Spitsin S, ... Frank I, et al. HIV Infection and Depression Among Opiate Users in a US Epicenter of the Opioid Epidemic. Aids and Behavior. PMID 33449236 DOI: 10.1007/s10461-020-03151-2  0.024
2017 Gulick RM, Wilkin TJ, Chen YQ, Landovitz RJ, Amico KR, Young AM, Richardson P, Marzinke MA, Hendrix CW, Eshleman SH, McGowan I, Cottle LM, Andrade A, Marcus C, Klingman KL, ... ... Frank I, et al. Safety and Tolerability of Maraviroc-Containing Regimens to Prevent HIV Infection in Women: A Phase 2 Randomized Trial. Annals of Internal Medicine. 1-10. PMID 28828489 DOI: 10.7326/M17-0520  0.024
2021 Bar KJ, Shaw PA, Choi GH, Aqui N, Fesnak A, Yang JB, Soto-Calderon H, Grajales L, Starr J, Andronov M, Mastellone M, Amonu C, Feret G, DeMarshall M, Buchanan M, ... ... Frank I, et al. A randomized controlled study of convalescent plasma for individuals hospitalized with COVID-19 pneumonia. The Journal of Clinical Investigation. PMID 34788233 DOI: 10.1172/JCI155114  0.024
2021 Momplaisir F, Frank I, Meyer W, Kim D, Kappes R, Tebas P. Vitamin D Levels, Natural H1N1 Infection and Response to H1N1 Vaccine among HIV-Infected Individuals. Journal of Aids & Clinical Research. 3: 152. PMID 23227442 DOI: 10.4172/2155-6113.1000152  0.023
2019 Li SS, Gilbert PB, Carpp LN, Pyo CW, Janes H, Fong Y, Shen X, Neidich SD, Goodman D, deCamp A, Cohen KW, Ferrari G, Hammer SM, Sobieszczyk ME, Mulligan MJ, ... ... Frank I, et al. Fc gamma receptor polymorphisms modulated the vaccine effect on HIV-1 risk in the HVTN 505 HIV vaccine trial. Journal of Virology. PMID 31434737 DOI: 10.1128/Jvi.02041-18  0.023
2016 Bednar MM, Hauser BM, Zhou S, Jacobson JM, Eron JJ, Frank I, Swanstrom R. Diversity and Tropism of HIV-1 Plasma Rebound Virus after Treatment Discontinuation. The Journal of Infectious Diseases. PMID 27132284 DOI: 10.1093/Infdis/Jiw172  0.023
2021 Apostolidis SA, Sarkar A, Giannini HM, Goel RR, Mathew D, Suzuki A, Baxter AE, Greenplate AR, Alanio C, Abdel-Hakeem M, Oldridge DA, Giles J, Wu JE, Chen Z, Huang YJ, ... ... Frank I, et al. Signaling through FcγRIIA and the C5a-C5aR pathway mediates platelet hyperactivation in COVID-19. Biorxiv : the Preprint Server For Biology. PMID 33972943 DOI: 10.1101/2021.05.01.442279  0.023
2016 Dinges W, Girard PM, Podzamczer D, Brockmeyer NH, García F, Harrer T, Lelievre JD, Frank I, Colin De Verdière N, Yeni GP, Ortega Gonzalez E, Rubio R, Clotet Sala B, DeJesus E, Pérez-Elias MJ, et al. The F4/AS01B HIV-1 Vaccine Candidate Is Safe and Immunogenic, But Does Not Show Viral Efficacy in Antiretroviral Therapy-Naive, HIV-1-Infected Adults: A Randomized Controlled Trial. Medicine. 95: e2673. PMID 26871794 DOI: 10.1097/Md.0000000000002673  0.023
2021 Sekabira R, Mcgowan I, Yuhas K, Brand RM, Marzinke MA, Manabe YC, Frank I, Eron J, Landovitz RJ, Anton P, Cranston RD, Anderson P, Mayer KH, Amico KR, Wilkin TJ, et al. Higher colorectal tissue HIV infectivity in cisgender women compared with MSM before and during oral preexposure prophylaxis. Aids (London, England). PMID 33831911 DOI: 10.1097/QAD.0000000000002907  0.022
2023 Wilson GJ, Rodriguez B, Li SS, Allen M, Frank I, Rudnicki E, Trahey M, Kalams S, Hannaman D, Clarke DK, Xu R, Egan M, Eldridge J, Pensiero M, Latham T, et al. Cellular and humoral responses to an HIV DNA prime by electroporation boosted with recombinant vesicular stomatitis virus expressing HIV subtype C Env in a randomized controlled clinical trial. Vaccine. PMID 36935288 DOI: 10.1016/j.vaccine.2023.03.015  0.021
2015 Beck JM, Schloss PD, Venkataraman A, Twigg H, Jablonski KA, Bushman FD, Campbell TB, Charlson ES, Collman RG, Crothers K, Curtis JL, Drews KL, Flores SC, Fontenot AP, Foulkes MA, ... Frank I, et al. Multicenter Comparison of Lung and Oral Microbiomes of HIV-infected and HIV-uninfected Individuals. American Journal of Respiratory and Critical Care Medicine. 192: 1335-44. PMID 26247840 DOI: 10.1164/Rccm.201501-0128Oc  0.021
2005 Wang FX, Xu Y, Sullivan J, Souder E, Argyris EG, Acheampong EA, Fisher J, Sierra M, Thomson MM, Najera R, Frank I, Kulkosky J, Pomerantz RJ, Nunnari G. IL-7 is a potent and proviral strain-specific inducer of latent HIV-1 cellular reservoirs of infected individuals on virally suppressive HAART. The Journal of Clinical Investigation. 115: 128-37. PMID 15630452 DOI: 10.1172/JCI22574  0.021
2021 Corey L, Gilbert PB, Juraska M, Montefiori DC, Morris L, Karuna ST, Edupuganti S, Mgodi NM, deCamp AC, Rudnicki E, Huang Y, Gonzales P, Cabello R, Orrell C, Lama JR, ... ... Frank I, et al. Two Randomized Trials of Neutralizing Antibodies to Prevent HIV-1 Acquisition. The New England Journal of Medicine. 384: 1003-1014. PMID 33730454 DOI: 10.1056/NEJMoa2031738  0.021
2021 Tomescu C, Kroll K, Colon K, Papasavvas E, Frank I, Tebas P, Mounzer K, Reeves RK, Montaner LJ. Identification of the predominant human NK cell effector subset mediating ADCC against HIV-infected targets coated with BNAbs or plasma from PLWH. European Journal of Immunology. PMID 34086344 DOI: 10.1002/eji.202149188  0.021
2017 Mayer KH, Seaton KE, Huang Y, Grunenberg N, Isaacs A, Allen M, Ledgerwood JE, Frank I, Sobieszczyk ME, Baden LR, Rodriguez B, Van Tieu H, Tomaras GD, Deal A, Goodman D, et al. Safety, pharmacokinetics, and immunological activities of multiple intravenous or subcutaneous doses of an anti-HIV monoclonal antibody, VRC01, administered to HIV-uninfected adults: Results of a phase 1 randomized trial. Plos Medicine. 14: e1002435. PMID 29136037 DOI: 10.1371/Journal.Pmed.1002435  0.021
2022 Apostolidis SA, Sarkar A, Giannini HM, Goel RR, Mathew D, Suzuki A, Baxter AE, Greenplate AR, Alanio C, Abdel-Hakeem M, Oldridge DA, Giles JR, Wu JE, Chen Z, Huang YJ, ... ... Frank I, et al. Signaling Through FcγRIIA and the C5a-C5aR Pathway Mediate Platelet Hyperactivation in COVID-19. Frontiers in Immunology. 13: 834988. PMID 35309299 DOI: 10.3389/fimmu.2022.834988  0.021
2013 Kim RJ, Vaghani S, Zifchak LM, Quinn JH, He W, Tebas P, Frank I. In vitro and in vivo effects of IGF-I on adiposity in HIV-associated metabolic disease: a pilot study. Archives of Medical Research. 44: 361-9. PMID 23867790 DOI: 10.1016/j.arcmed.2013.06.001  0.021
2021 Goepfert PA, Fu B, Chabanon AL, Bonaparte MI, Davis MG, Essink BJ, Frank I, Haney O, Janosczyk H, Keefer MC, Koutsoukos M, Kimmel MA, Masotti R, Savarino SJ, Schuerman L, et al. Safety and immunogenicity of SARS-CoV-2 recombinant protein vaccine formulations in healthy adults: interim results of a randomised, placebo-controlled, phase 1-2, dose-ranging study. The Lancet. Infectious Diseases. PMID 33887209 DOI: 10.1016/S1473-3099(21)00147-X  0.02
2021 Resnick D, Morales K, Gross R, Petsis D, Fiore D, Davis-Vogel A, Metzger D, Frank I, Wood S. Prior Sexually Transmitted Infection and Human Immunodeficiency Virus Risk Perception in a Diverse At-Risk Population of Men Who Have Sex with Men and Transgender Individuals. Aids Patient Care and Stds. 35: 15-22. PMID 33400589 DOI: 10.1089/apc.2020.0179  0.02
2007 Lo Re V, Frank I, Gross R, Synnestvedt M, Localio AR, Kostman JR, Strom BL. Self-reported hepatitis B and C virus infections had low sensitivity among HIV-infected patients. Journal of Clinical Epidemiology. 60: 294-9. PMID 17292024 DOI: 10.1016/J.Jclinepi.2006.06.020  0.02
2014 Yehia BR, Schranz AJ, Momplaisir F, Keller SC, Gross R, Frank I, Metlay JP, Brady KA. Outcomes of HIV-infected patients receiving care at multiple clinics. Aids and Behavior. 18: 1511-22. PMID 24077931 DOI: 10.1007/S10461-013-0625-7  0.02
2013 Metch B, Frank I, Novak R, Swann E, Metzger D, Morgan C, Lucy D, Dunbar D, Graham P, Madenwald T, Escamilia G, Koblin B. Recruitment of urban US women at risk for HIV infection and willingness to participate in future HIV vaccine trials. Aids and Behavior. 17: 760-72. PMID 23090677 DOI: 10.1007/S10461-012-0351-6  0.02
2023 Chirenje ZM, Laher F, Dintwe O, Muyoyeta M, deCamp AC, He Z, Grunenberg N, Laher Omar F, Seaton KE, Polakowski L, Woodward Davis AS, Maganga L, Baden LR, Mayer K, Kalams S, ... ... Frank I, et al. Protein dose-sparing effect of AS01B adjuvant in a randomized preventive HIV vaccine trial of ALVAC-HIV (vCP2438) and adjuvanted bivalent subtype C gp120. The Journal of Infectious Diseases. PMID 37795976 DOI: 10.1093/infdis/jiad434  0.02
2018 Fong Y, Shen X, Ashley VC, Deal A, Seaton KE, Yu C, Grant SP, Ferrari G, deCamp AC, Bailer RT, Koup RA, Montefiori D, Haynes BF, Sarzotti-Kelsoe M, Graham BS, ... ... Frank I, et al. Vaccine-induced antibody responses modify the association between T-cell immune responses and HIV-1 infection risk in HVTN 505. The Journal of Infectious Diseases. PMID 29325070 DOI: 10.1093/Infdis/Jiy008  0.019
2010 Tebas P, Frank I, Lewis M, Quinn J, Zifchak L, Thomas A, Kenney T, Kappes R, Wagner W, Maffei K, Sullivan K. Poor immunogenicity of the H1N1 2009 vaccine in well controlled HIV-infected individuals. Aids (London, England). 24: 2187-92. PMID 20616698 DOI: 10.1097/QAD.0b013e32833c6d5c  0.019
2019 Del Alcazar D, Wang Y, He C, Wendel BS, Del Río-Estrada PM, Lin J, Ablanedo-Terrazas Y, Malone MJ, Hernandez SM, Frank I, Naji A, Reyes-Terán G, Jiang N, Su LF. Mapping the Lineage Relationship between CXCR5 and CXCR5 CD4 T Cells in HIV-Infected Human Lymph Nodes. Cell Reports. 28: 3047-3060.e7. PMID 31533030 DOI: 10.1016/J.Celrep.2019.08.037  0.018
2018 Elizaga ML, Li SS, Kochar NK, Wilson GJ, Allen MA, Tieu HVN, Frank I, Sobieszczyk ME, Cohen KW, Sanchez B, Latham TE, Clarke DK, Egan MA, Eldridge JH, Hannaman D, et al. Safety and tolerability of HIV-1 multiantigen pDNA vaccine given with IL-12 plasmid DNA via electroporation, boosted with a recombinant vesicular stomatitis virus HIV Gag vaccine in healthy volunteers in a randomized, controlled clinical trial. Plos One. 13: e0202753. PMID 30235286 DOI: 10.1371/journal.pone.0202753  0.018
2013 Yehia BR, Kangovi S, Frank I. Patients in transition: avoiding detours on the road to HIV treatment success. Aids (London, England). 27: 1529-33. PMID 23435297 DOI: 10.1097/QAD.0b013e328360104e  0.018
2018 Abdel-Mohsen M, Kuri-Cervantes L, Grau-Exposito J, Spivak AM, Nell RA, Tomescu C, Vadrevu SK, Giron LB, Serra-Peinado C, Genescà M, Castellví J, Wu G, Del Rio Estrada PM, González-Navarro M, Lynn K, ... ... Frank I, et al. CD32 is expressed on cells with transcriptionally active HIV but does not enrich for HIV DNA in resting T cells. Science Translational Medicine. 10. PMID 29669853 DOI: 10.1126/Scitranslmed.Aar6759  0.018
2002 Chen W, Sulcove J, Frank I, Jaffer S, Ozdener H, Kolson DL. Development of a human neuronal cell model for human immunodeficiency virus (HIV)-infected macrophage-induced neurotoxicity: apoptosis induced by HIV type 1 primary isolates and evidence for involvement of the Bcl-2/Bcl-xL-sensitive intrinsic apoptosis pathway. Journal of Virology. 76: 9407-19. PMID 12186923 DOI: 10.1128/Jvi.76.18.9407-9419.2002  0.018
2006 Hodder S, Frank I. Antiretroviral rounds. CD4 count 423, viral load 12,000: time to treat anyway? Aids Clinical Care. 18: 59-60. PMID 16791955  0.017
2018 Schnoll RA, Thompson M, Serrano K, Leone F, Metzger D, Frank I, Gross R, Mounzer K, Tyndale RF, Weisbrot J, Meline M, Collman RG, Ashare RL. Rate of Nicotine Metabolism and Tobacco Use among Persons with HIV: Implications for Treatment and Research. Journal of Acquired Immune Deficiency Syndromes (1999). PMID 30399039 DOI: 10.1097/Qai.0000000000001895  0.017
2022 Blumberg EA, Noll JH, Tebas P, Fraietta JA, Frank I, Marshall AE, Chew A, Veloso EA, Carulli A, Rogal W, Gaymon AL, Schmidt AH, Barnette T, Jurek R, Martins R, et al. Phase 1 trial of cyclosporine for hospitalized patients with COVID-19. Jci Insight. PMID 35536669 DOI: 10.1172/jci.insight.155682  0.017
2006 Horton H, Frank I, Baydo R, Jalbert E, Penn J, Wilson S, McNevin JP, McSweyn MD, Lee D, Huang Y, De Rosa SC, McElrath MJ. Preservation of T cell proliferation restricted by protective HLA alleles is critical for immune control of HIV-1 infection. Journal of Immunology (Baltimore, Md. : 1950). 177: 7406-15. PMID 17082660  0.017
2016 Fishman J, Taylor L, Frank I. Awareness of HPV and Uptake of Vaccination in a High-Risk Population. Pediatrics. PMID 27440659 DOI: 10.1542/Peds.2015-2048  0.017
2013 Brawner BM, Baker JL, Voytek CD, Leader A, Cashman RR, Silverman R, Peter N, Buchner BJ, Barnes CA, Jemmott LS, Frank I. The development of a culturally relevant, theoretically driven HPV prevention intervention for urban adolescent females and their parents/guardians. Health Promotion Practice. 14: 624-36. PMID 23099659 DOI: 10.1177/1524839912462389  0.017
2017 Meyers K, Rodriguez K, Brill AL, Wu Y, La Mar M, Dunbar D, Koblin B, Margolis D, Sobieszczyk ME, Van Tieu H, Frank I, Markowitz M, Golub SA. Lessons for Patient Education Around Long-Acting Injectable PrEP: Findings from a Mixed-Method Study of Phase II Trial Participants. Aids and Behavior. PMID 28744666 DOI: 10.1007/S10461-017-1871-X  0.016
2021 Landovitz RJ, Donnell D, Clement ME, Hanscom B, Cottle L, Coelho L, Cabello R, Chariyalertsak S, Dunne EF, Frank I, Gallardo-Cartagena JA, Gaur AH, Gonzales P, Tran HV, Hinojosa JC, et al. Cabotegravir for HIV Prevention in Cisgender Men and Transgender Women. The New England Journal of Medicine. 385: 595-608. PMID 34379922 DOI: 10.1056/NEJMoa2101016  0.016
2005 Frank I, Shulman N. Antiretroviral rounds. When to rock the boat? Aids Clinical Care. 16: 90, 94. PMID 15595166  0.016
2010 Gordon SN, Cervasi B, Odorizzi P, Silverman R, Aberra F, Ginsberg G, Estes JD, Paiardini M, Frank I, Silvestri G. Disruption of intestinal CD4+ T cell homeostasis is a key marker of systemic CD4+ T cell activation in HIV-infected individuals. Journal of Immunology (Baltimore, Md. : 1950). 185: 5169-79. PMID 20889546 DOI: 10.4049/Jimmunol.1001801  0.016
2016 Gulick RM, Wilkin TJ, Chen YQ, Landovitz RJ, Amico KR, Young AM, Richardson P, Marzinke MA, Hendrix CW, Eshleman SH, McGowan I, Cottle LM, Andrade A, Marcus C, Klingman KL, ... ... Frank I, et al. PHASE 2 STUDY OF THE SAFETY AND TOLERABILITY OF MARAVIROC-CONTAINING REGIMENS TO PREVENT HIV INFECTION IN MEN WHO HAVE SEX WITH MEN (MSM) (HPTN 069/ACTG A5305). The Journal of Infectious Diseases. PMID 27811319 DOI: 10.1093/Infdis/Jiw525  0.016
2002 Nunnari G, Otero M, Dornadula G, Vanella M, Zhang H, Frank I, Pomerantz RJ. Residual HIV-1 disease in seminal cells of HIV-1-infected men on suppressive HAART: latency without on-going cellular infections. Aids (London, England). 16: 39-45. PMID 11741161 DOI: 10.1097/00002030-200201040-00006  0.016
2008 Brenchley JM, Paiardini M, Knox KS, Asher AI, Cervasi B, Asher TE, Scheinberg P, Price DA, Hage CA, Kholi LM, Khoruts A, Frank I, Else J, Schacker T, Silvestri G, et al. Differential Th17 CD4 T-cell depletion in pathogenic and nonpathogenic lentiviral infections. Blood. 112: 2826-35. PMID 18664624 DOI: 10.1182/Blood-2008-05-159301  0.016
2021 Karuna S, Li SS, Grant S, Walsh SR, Frank I, Casapia M, Trahey M, Hyrien O, Fisher L, Miner MD, Randhawa AK, Polakowski L, Kublin JG, Corey L, Montefiori D, et al. Neutralizing antibody responses over time in demographically and clinically diverse individuals recovered from SARS-CoV-2 infection in the United States and Peru: A cohort study. Plos Medicine. 18: e1003868. PMID 34871308 DOI: 10.1371/journal.pmed.1003868  0.016
2018 Murray MI, Markowitz M, Frank I, Grant RM, Mayer KH, Hudson KJ, Stancil BS, Ford SL, Patel P, Rinehart AR, Spreen WR, Margolis DA. Satisfaction and acceptability of cabotegravir long-acting injectable suspension for prevention of HIV: Patient perspectives from the ECLAIR trial. Hiv Clinical Trials. 1-10. PMID 30445896 DOI: 10.1080/15284336.2018.1511346  0.016
2008 Torti C, Frank I. A king in the CASTLE? Optimum initial HIV protease inhibitor. Lancet (London, England). 372: 604-6. PMID 18722849 DOI: 10.1016/S0140-6736(08)61253-2  0.015
2003 Frank I. Antivirals against HIV-1. Clinics in Laboratory Medicine. 22: 741-57, vii. PMID 12244595 DOI: 10.1016/s0272-2712(02)00016-1  0.015
2021 Goel RR, Painter MM, Apostolidis SA, Mathew D, Meng W, Rosenfeld AM, Lundgreen KA, Reynaldi A, Khoury DS, Pattekar A, Gouma S, Kuri-Cervantes L, Hicks P, Dysinger S, Hicks A, ... ... Frank I, et al. mRNA Vaccination Induces Durable Immune Memory to SARS-CoV-2 with Continued Evolution to Variants of Concern. Biorxiv : the Preprint Server For Biology. PMID 34462751 DOI: 10.1101/2021.08.23.457229  0.015
2022 Mayer KH, Yuhas K, Amico KR, Wilkin T, Landovitz RJ, Richardson P, Marzinke MA, Hendrix CW, Eshleman SH, Cottle LM, Marcus C, Chege W, Rinehart AR, Rooney JF, Andrew P, ... ... Frank I, et al. Sexual behavior and medication adherence in men who have sex with men participating in a pre-exposure prophylaxis study of combinations of Maraviroc, Tenofovir Disoproxil Fumarate and/or Emtricitabine (HPTN 069/ACTG 5305). Aids and Behavior. PMID 35687192 DOI: 10.1007/s10461-022-03736-z  0.014
2021 Gouma S, Weirick ME, Bolton MJ, Arevalo CP, Goodwin EC, Anderson EM, McAllister CM, Christensen SR, Dunbar D, Fiore D, Brock A, Weaver J, Millar J, DerOhannessian S, ... Frank I, et al. Sero-monitoring of health care workers reveals complex relationships between common coronavirus antibodies and SARS-CoV-2 severity. Medrxiv : the Preprint Server For Health Sciences. PMID 33907765 DOI: 10.1101/2021.04.12.21255324  0.014
2013 Hammer SM, Sobieszczyk ME, Janes H, Karuna ST, Mulligan MJ, Grove D, Koblin BA, Buchbinder SP, Keefer MC, Tomaras GD, Frahm N, Hural J, Anude C, Graham BS, Enama ME, ... ... Frank I, et al. Efficacy trial of a DNA/rAd5 HIV-1 preventive vaccine. The New England Journal of Medicine. 369: 2083-92. PMID 24099601 DOI: 10.1056/Nejmoa1310566  0.014
2013 Kalams SA, Parker SD, Elizaga M, Metch B, Edupuganti S, Hural J, De Rosa S, Carter DK, Rybczyk K, Frank I, Fuchs J, Koblin B, Kim DH, Joseph P, Keefer MC, et al. Safety and comparative immunogenicity of an HIV-1 DNA vaccine in combination with plasmid interleukin 12 and impact of intramuscular electroporation for delivery. The Journal of Infectious Diseases. 208: 818-29. PMID 23840043 DOI: 10.1093/Infdis/Jit236  0.014
2003 Otero M, Nunnari G, Leto D, Sullivan J, Wang FX, Frank I, Xu Y, Patel C, Dornadula G, Kulkosky J, Pomerantz RJ. Peripheral blood Dendritic cells are not a major reservoir for HIV type 1 in infected individuals on virally suppressive HAART. Aids Research and Human Retroviruses. 19: 1097-103. PMID 14709246 DOI: 10.1089/088922203771881194  0.013
2006 Foulkes AS, Wohl DA, Frank I, Puleo E, Restine S, Wolfe ML, Dube MP, Tebas P, Reilly MP. Associations among race/ethnicity, ApoC-III genotypes, and lipids in HIV-1-infected individuals on antiretroviral therapy. Plos Medicine. 3: e52. PMID 16417409 DOI: 10.1371/Journal.Pmed.0030052  0.012
2014 Ramirez LA, Daniel A, Frank I, Tebas P, Boyer JD. Seroprotection of HIV-infected subjects after influenza A(H1N1) vaccination is directly associated with baseline frequency of naive T cells. The Journal of Infectious Diseases. 210: 646-50. PMID 24610877 DOI: 10.1093/infdis/jiu132  0.012
2007 Lo Re V, Kostman JR, Gross R, Reddy KR, Mounzer K, Zemel BS, Rennert H, Stieritz DD, Putt M, Frank I, Strom BL. Incidence and risk factors for weight loss during dual HIV/hepatitis C virus therapy. Journal of Acquired Immune Deficiency Syndromes (1999). 44: 344-50. PMID 17179767 DOI: 10.1097/Qai.0B013E31802F12D3  0.012
2018 Tsima B, Ratcliffe SJ, Schnoll R, Frank I, Kolson DL, Gross R. Is Tobacco Use Associated with Neurocognitive Dysfunction in Individuals with HIV? Journal of the International Association of Providers of Aids Care. 17: 2325958218768018. PMID 29667531 DOI: 10.1177/2325958218768018  0.011
2022 Watson DL, Shaw PA, Petsis DT, Pickel J, Bauermeister JA, Frank I, Wood SM, Gross R. A retrospective study of HIV pre-exposure prophylaxis counselling among non-Hispanic Black youth diagnosed with bacterial sexually transmitted infections in the United States, 2014-2019. Journal of the International Aids Society. 25: e25867. PMID 35192740 DOI: 10.1002/jia2.25867  0.011
2005 Amorosa V, Synnestvedt M, Gross R, Friedman H, MacGregor RR, Gudonis D, Frank I, Tebas P. A tale of 2 epidemics: the intersection between obesity and HIV infection in Philadelphia. Journal of Acquired Immune Deficiency Syndromes (1999). 39: 557-61. PMID 16044007  0.011
2021 Cohen MS, Nirula A, Mulligan MJ, Novak RM, Marovich M, Yen C, Stemer A, Mayer SM, Wohl D, Brengle B, Montague BT, Frank I, McCulloh RJ, Fichtenbaum CJ, Lipson B, et al. Effect of Bamlanivimab vs Placebo on Incidence of COVID-19 Among Residents and Staff of Skilled Nursing and Assisted Living Facilities: A Randomized Clinical Trial. Jama. PMID 34081073 DOI: 10.1001/jama.2021.8828  0.01
2021 Goel RR, Painter MM, Apostolidis SA, Mathew D, Meng W, Rosenfeld AM, Lundgreen KA, Reynaldi A, Khoury DS, Pattekar A, Gouma S, Kuri-Cervantes L, Hicks P, Dysinger S, Hicks A, ... ... Frank I, et al. mRNA vaccines induce durable immune memory to SARS-CoV-2 and variants of concern. Science (New York, N.Y.). eabm0829. PMID 34648302 DOI: 10.1126/science.abm0829  0.01
2014 Fishman J, Taylor L, Kooker P, Frank I. Parent and Adolescent Knowledge of HPV and Subsequent Vaccination Pediatrics. 134. PMID 25225141 DOI: 10.1542/Peds.2013-3454  0.01
2007 Boyle BA, Elion R, Cohen CJ, Moyle GJ, Sax P, Frank I. Advances in HIV therapeutics: the 14th CROI. The Aids Reader. 17: 268-70, 272-4, 283-6. PMID 17532664  0.01
2008 Dunham RM, Cervasi B, Brenchley JM, Albrecht H, Weintrob A, Sumpter B, Engram J, Gordon S, Klatt NR, Frank I, Sodora DL, Douek DC, Paiardini M, Silvestri G. CD127 and CD25 expression defines CD4+ T cell subsets that are differentially depleted during HIV infection. Journal of Immunology (Baltimore, Md. : 1950). 180: 5582-92. PMID 18390743 DOI: 10.4049/Jimmunol.180.8.5582  0.01
2022 Yuh T, Srivastava T, Fiore D, Schmidt H, Frank I, Metzger D, Momplaisir F. Using a patient portal as a recruitment tool to diversify the pool of participants in COVID-19 vaccine clinical trials. Jamia Open. 5: ooac091. PMID 36380851 DOI: 10.1093/jamiaopen/ooac091  0.01
2022 Anderson EM, Li SH, Awofolaju M, Eilola T, Goodwin E, Bolton MJ, Gouma S, Manzoni TB, Hicks P, Goel RR, Painter MM, Apostolidis SA, Mathew D, Dunbar D, Fiore D, ... ... Frank I, et al. SARS-CoV-2 infections elicit higher levels of original antigenic sin antibodies compared with SARS-CoV-2 mRNA vaccinations. Cell Reports. 41: 111496. PMID 36261003 DOI: 10.1016/j.celrep.2022.111496  0.01
2021 Momplaisir FM, Kuter BJ, Ghadimi F, Browne S, Nkwihoreze H, Feemster KA, Frank I, Faig W, Shen AK, Offit PA, Green-McKenzie J. Racial/Ethnic Differences in COVID-19 Vaccine Hesitancy Among Health Care Workers in 2 Large Academic Hospitals. Jama Network Open. 4: e2121931. PMID 34459907 DOI: 10.1001/jamanetworkopen.2021.21931  0.01
2021 Gouma S, Weirick ME, Bolton MJ, Arevalo CP, Goodwin EC, Anderson EM, McAllister CM, Christensen SR, Dunbar D, Fiore D, Brock A, Weaver J, Millar JS, DerOhannessian S, Frank I, et al. Health care worker sero-monitoring reveals complex relationships between common coronavirus antibodies and COVID-19 symptom duration. Jci Insight. PMID 34237028 DOI: 10.1172/jci.insight.150449  0.01
2020 Abella BS, Jolkovsky EL, Biney BT, Uspal JE, Hyman MC, Frank I, Hensley SE, Gill S, Vogl DT, Maillard I, Babushok DV, Huang AC, Nasta SD, Walsh JC, Wiletyo EP, et al. Efficacy and Safety of Hydroxychloroquine vs Placebo for Pre-exposure SARS-CoV-2 Prophylaxis Among Health Care Workers: A Randomized Clinical Trial. Jama Internal Medicine. PMID 33001138 DOI: 10.1001/jamainternmed.2020.6319  0.01
2018 Kolomeyer AM, Murphy KM, Traband A, Frank I, Kim BJ. BETA-D-GLUCAN TESTING IN PATIENTS WITH FUNGAL ENDOPHTHALMITIS. Retina (Philadelphia, Pa.). PMID 29370030 DOI: 10.1097/IAE.0000000000002049  0.01
2017 Buckingham L, Becher J, Voytek CD, Fiore D, Dunbar D, Davis-Vogel A, Metzger DS, Frank I. Going social: Success in online recruitment of men who have sex with men for prevention HIV vaccine research. Vaccine. PMID 28526330 DOI: 10.1016/j.vaccine.2017.05.002  0.01
2015 Ravimohan S, Tamuhla N, Nfanyana K, Steenhoff AP, Letlhogile R, Frank I, MacGregor RR, Gross R, Weissman D, Bisson GP. Robust Reconstitution of Tuberculosis-Specific Polyfunctional CD4+ T-Cell Responses and Rising Systemic Interleukin 6 in Paradoxical Tuberculosis-Associated Immune Reconstitution Inflammatory Syndrome. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 26611774 DOI: 10.1093/Cid/Civ978  0.01
2013 Cerosaletti K, Schneider A, Schwedhelm K, Frank I, Tatum M, Wei S, Whalen E, Greenbaum C, Kita M, Buckner J, Long SA. Multiple autoimmune-associated variants confer decreased IL-2R signaling in CD4+ CD25(hi) T cells of type 1 diabetic and multiple sclerosis patients. Plos One. 8: e83811. PMID 24376757 DOI: 10.1371/journal.pone.0083811  0.01
2013 Ravimohan S, Tamuhla N, Steenhoff AP, Letlhogile R, Makutu DK, Nfanyana K, Rantleru T, Tierney A, Nkakana K, Schwartz AB, Gross R, Macgregor RR, Bellamy SL, Frank I, Weissman D, et al. Early immunologic failure is associated with early mortality among advanced HIV-infected adults initiating antiretroviral therapy with active tuberculosis. The Journal of Infectious Diseases. 208: 1784-93. PMID 23908475 DOI: 10.1093/Infdis/Jit368  0.01
2013 Azzoni L, Foulkes AS, Papasavvas E, Mexas AM, Lynn KM, Mounzer K, Tebas P, Jacobson JM, Frank I, O'Doherty U, Kostman J, Montaner LJ. Improved treatment for primary HIV infection by interferon-alfa therapy? Does HCV treatment in HIV/HCV coinfected patients help us to test this hypothesis? Reply to zur Wiesch and van Lunzen. The Journal of Infectious Diseases. 208: 363. PMID 23570845 DOI: 10.1093/Infdis/Jit160  0.01
2013 Gutierrez B, Leung A, Jones KT, Smith P, Silverman R, Frank I, Leader AE. Acceptability of the human papillomavirus vaccine among urban adolescent males. American Journal of Men's Health. 7: 27-36. PMID 22892147 DOI: 10.1177/1557988312456697  0.01
2012 Merlin JS, Cen L, Praestgaard A, Turner M, Obando A, Alpert C, Woolston S, Casarett D, Kostman J, Gross R, Frank I. Pain and physical and psychological symptoms in ambulatory HIV patients in the current treatment era. Journal of Pain and Symptom Management. 43: 638-45. PMID 22115794 DOI: 10.1016/j.jpainsymman.2011.04.019  0.01
2011 Leader AE, Cashman R, Voytek CD, Baker JL, Brawner BM, Frank I. An exploratory study of adolescent female reactions to direct-to-consumer advertising: the case of the Human Papillomavirus (HPV) Vaccine. Health Marketing Quarterly. 28: 372-85. PMID 22054031 DOI: 10.1080/07359683.2011.630289  0.01
2010 Smallwood RA, Frank I, Walters T. The Australian Medical Council: beyond the first 25 years. The Medical Journal of Australia. 193: 566-7. PMID 21077809 DOI: 10.5694/j.1326-5377.2010.tb04061.x  0.01
2009 Boyle BA, Cohen CJ, DeJesus E, Elion R, Frank I, Moyle GJ, Sax PE. Select updates from the 16th CROI: treatment-related cardiovascular risk, pharmacokinetic issues, and interleukin-2 use. The Aids Reader. 19: 158-60. PMID 19388184  0.01
2009 Boyle BA, Cohen CJ, DeJesus E, Elion R, Frank I, Moyle GJ, Sax P. Antiretroviral therapy update from the 48th ICAAC/46th IDSA annual meeting. The Aids Reader. 19: 22-31. PMID 19209453  0.01
2008 Boyle B, Cohen C, DeJesus E, Elion R, Frank I, Moyle G, Sax P. Antiretroviral treatment update from the 17th International AIDS Conference. The Aids Reader. 18: 570-9. PMID 19062402  0.01
2008 Boyle BA, Cohen CJ, DeJesus E, Elion R, Frank I, Moyle GJ, Sax P. Update on antiretroviral therapy: the 15th CROI. The Aids Reader. 18: 273-8, C3. PMID 18589484  0.01
2007 Eron JJ, Bosch RJ, Bettendorf D, Petch L, Fiscus S, Frank I. The effect of lamivudine therapy and M184V on the antiretroviral activity of didanosine. Journal of Acquired Immune Deficiency Syndromes (1999). 45: 249-51. PMID 17527095 DOI: 10.1097/QAI.0b013e318050d61f  0.01
2006 Boyle BA, Cohen CJ, Moyle GJ, Elion R, Sax PE, Frank I. XVI International AIDS Conference: Part 2. The Aids Reader. 16: 581-4, 591-2. PMID 17152645  0.01
2006 Boyle BA, Cohen CJ, Moyle GJ, Elion R, Sax PE, Frank I. XVI International AIDS Conference: Part 1. The Aids Reader. 16: 517-21. PMID 17096469  0.01
2005 Hivnor CM, Nguyen V, Rook AH, Junkins-Hopkins J, Gelfand JM, Nasta S, Frank I, Kim EJ. CD8+ lymphoma in a patient with human immunodeficiency virus. Archives of Dermatology. 141: 1321-2. PMID 16230579 DOI: 10.1001/ARCHDERM.141.10.1321  0.01
2002 Frank I. Once-daily HAART: toward a new treatment paradigm. Journal of Acquired Immune Deficiency Syndromes (1999). S10-5; discussion S2. PMID 12218439 DOI: 10.1097/00126334-200209011-00003  0.01
1967 Frank IW. Die Spannung zwischen Ordensleben und wissenschaftlicher Arbeit im frühen Dominikanerorden Archiv Fur Kulturgeschichte. 49: 164-207. DOI: 10.7788/akg-1967-jg09  0.01
Hide low-probability matches.